NDTV spoke today to the manufacturer of the recently-cleared Covid pill for India. US pharma giant Merck has licensed the Molnupiravir to more than a dozen firms that will manufacture it in India.
Here's what we know now about this pill after a detailed interview with Dr D Srinivas Reddy, the top boss at Optimus Pharma, one of the companies which will make the pill after emergency approval was given two days ago.
- In trials in India involving more than 1,000 people, most patients who took the full course tested negative after five days.
- This is a prescription-only pill, it will not be available over-the-counter.
- Cost of the full course is Rs 2,500 but this price could reduce over time to Rs 400 per course.
- The full five-day course consists of 8 tablets per day.
- Take 4 pills in the morning (on empty stomach) and 4 in the evening.
- The early rollout of the pill will focus on making it available in metros.
- The pill will be available for use in a week.
Dr Reddy of Optimus Pharma said the company is also in talks to make a second Covid pill, PAXLOVID, which was developed by Pfizer and which shows an efficacy of 90% as compared to 30% for Molnupiravir.
Once emergency approval is obtained for the Pfizer version, it could be ready for use in India by Optimus in five to six months, Dr Reddy claimed. He said it will be much more expensive than Molnupiravir and could cost as much as four times the price of the Merck pill which will be deployed in a week.
US Lawmakers Back Covid Chinese Lab Leak Theory After Two-Year Probe A Call, Digital Arrest, Rs 7 Crore Transferred: How Vardhman Boss Was Duped New XEC Covid Variant Spreads To 27 Countries, Here's What We Know So Far 12 Dead, Many Critical In Jaipur Fire As 2 Trucks Collide Outside Petrol Pump Video: Bird's-Eye View Of Devastation After Jaipur Accident That Killed 12 Tabla Legend Zakir Hussain's Funeral Held In San Francisco UK PM Keir Starmer Nominates Indian-Origin Krish Raval For Peerage Key Ally To Canada PM Trudeau Says He Will Vote To Bring Him Down Luigi Mangione Case Exposes Dangers Of 3D Printed Firearms Track Latest News Live on NDTV.com and get news updates from India and around the world.